Investing Ideas
/
Canadian Pharmaceuticals & Biotech Precious Metals

Header cover image

Canadian Pharmaceuticals & Biotech Precious Metals

UPDATED Mar 14, 2024

Gold, Silver and Precious Metals companies ordered by Snowflake size.

11 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	GTII Green Thumb Industries	CA$15.69	0.8%	42.0%	CA$3.7b	CA$24.50	PE76.2x	E26.5%	n/a
	MDP Medexus Pharmaceuticals	CA$1.55	-10.4%	5.4%	CA$39.1m	CA$3.25	PE4.8x	E50.1%	n/a
	HITI High Tide	CA$2.25	3.2%	47.1%	CA$179.2m	CA$5.95	PB1.3x	E109.9%	n/a
	ROMJ Rubicon Organics	CA$0.38	-3.8%	-39.5%	CA$20.8m	CA$1.40	PB0.6x	E163.9%	n/a
	DB Decibel Cannabis	CA$0.10	-9.1%	-33.3%	CA$42.9m	n/a	PB0.9x	E102.9%	n/a
	NUMI Numinus Wellness	CA$0.10	-12.5%	-46.2%	CA$33.7m	n/a	PS1.4x	E70.2%	n/a
	GUD Knight Therapeutics	CA$5.32	-3.4%	5.8%	CA$534.2m	CA$6.56	PS1.6x	E45.5%	n/a
	HLS HLS Therapeutics	CA$3.99	-5.7%	-44.4%	CA$138.7m	CA$6.93	PS1.5x	E67.8%	0%
	CRON Cronos Group	CA$2.70	1.5%	-3.9%	CA$1.0b	CA$3.39	PS8.7x	E59.8%	n/a
	CL Cresco Labs	CA$2.28	11.2%	-3.4%	CA$1.1b	CA$5.40	PB1.4x	E145.7%	n/a
	OGI Organigram Holdings	CA$2.53	-5.9%	-29.7%	CA$243.3m	CA$3.39	PS1.6x	E126.6%	n/a

Page 1 of 1